Coronavirus Outbreak to Shift US-China Trade, Says Financier

by FDeditor

An American flag flies with shipping containers stacked at the Port of Los Angeles in the background, which is the nation’s busiest container port in California, San Pedro, on Nov. 7, 2019. (Mario Tama/Getty Images)

China’s lack of transparency during the coronavirus outbreak will change the way American investors do business with it, according to an economics and financial advisor.

Since the beginning of the COVID-19 outbreak, mainland China has suppressed information about the virus. It has also started a propaganda narrative claiming that the virus originated in the United States.

But as the virus spreads, the pandemic facing the world could lead to a shift in U.S.-China trade.

“If they don’t show the world that they’re under control, if they’re not more transparent, to the public, to the world, [and] keep hiding their little things, people lose trust,” said President and CEO of Blackhawk Partners Zaid Abdelnour in an interview with NTD News. “Smart money wants transparency, wants openness.”

He added that the outbreak has exposed how heavily the United States relies on China. For example, the United States ran into a shortage of face masks when China stopped producing them.

Medication is another example. Rosemary Gibson from the Hastings Center Research Institute testified before a Senate committee on March 12 on the potential risks to national security posed by current dynamics in two-way trade.

Her testimony states that “90 percent of the chemical ingredients for generics in the U.S. to care for people with serious coronavirus infections and [those that] are hospitalized are sourced from China.” She said that drugs like sedatives, antibiotics, and others fall into this list.

But Abdelnour said the outbreak is helping people wake up to this reliance, adding that the “U.S.-China relationship is changing already, and it’s going to change even further.”

Zaid Abdelnour

President and CEO of Blackhawk Partners Inc. is interview by NTD News. (NTD News)

Gibson added that heavy dependance on another country for medicine is a national security risk because it can be weaponized.

She cited a threat that Xinhua, a Chinese state-owned media, published this month: “If China retaliates against the U.S. at this time, in addition to announcing a travel ban on the United States, it will also announce strategic control over medical products and ban exports to the United States.

“If China announces that its drugs are for domestic use and bans exports, the United States will fall into the hell of a new coronavirus epidemic,” it said.


You may also like

Leave a Comment